The Arizona Department of Health Services Bureau of Tobacco Education and Prevention began its strategic planning process in August of 2007 and aimed to create a model that focused on effective tobacco control which would engage stakeholders at the local, state and national levels. As such it was critical to ensure that the process was both transparent and participatory, and included input and involvement from the full diversity of populations and regions across Arizona.

The Arizona Department of Health Services initiated the development of this plan with the intent to set priorities by formulating objectives and suggesting strategies to address chronic obstructive pulmonary disease as a serious public health issue in Arizona. This plan begins with a detailed description of chronic obstructive lung disease followed by a discussion of proposed objectives and strategies. The overriding goals of this plan are those stated in the Healthy People 2010: Objectives for Improving Health.

Adult tobacco use represents an important and ongoing morbidity, mortality and health care cost problem. The Arizona Department of Health Services Tobacco Education and Prevention Program has been working since 1996 to reduce tobacco use in Arizona. This report presents data from the 2005 Adult Tobacco Surveys in Spanish on adult tobacco use prevalence rates, cessation behaviors, and home smoking bans.

The Arizona Department of Health Services sponsored the development of this plan with the intent to set priorities and suggest strategies to address asthma as a serious chronic disease and public health issue. The plan continues the focus placed on asthma in the Healthy People 2010 report. The plan is meant to serve as an ambitious and comprehensive approach to improving the health and quality of life for those with asthma living in Arizona.

Arizona’s vulnerable populations are struggling on a daily basis but usually do so in silence, undetected by traditional radar and rankings, often unaware themselves of their high risk for being pushed or pulled into full crisis. Ineligible for financial assistance under strict eligibility guidelines, they don’t qualify as poor because vulnerable populations are not yet in full crisis. To be clear, this report is not about the “poor,” at least not in the limited sense of the word. It is about our underemployed wage earners, our single-parent households, our deployed or returning military members, our under-educated and unskilled workforce, our debt-ridden neighbors, our uninsured friends, our family members with no savings for an emergency, much less retirement.

Arizona's recently adopted budget for fiscal year 2015-16 includes dramatic reductions in assistance to low-income families with children. On July 1, Arizona will become the first and only state to limit lifetime eligibility requirements for recipients of Temporary Assistance for Needy Families (TANF) to 12 months (federal law allows for eligibility time limits of 60 months). That means come June 30, 2016, many Arizona families no longer will receive TANF benefits even if they otherwise would be eligible under federal guidelines.

More than one in 10 Arizona public high school students have disabilities. One-third of these youth remain unengaged in work or education following graduation, creating a significant public policy challenge for the state. Why is this so? This report shares findings from 2014 surveys and focus groups conducted with youth and families as well as interviews with education leaders across the state. These responses highlight how Arizona schools and families are preparing these youth, and what the state still needs to do to ensure youth with disabilities have a role to play in Arizona’s job market.

Report takes a look at the pros and cons of three propositions that will be on the November 2014 ballot.
* Prop 122: a constitutional amendment to allow the Legislature to ignore any federal law or action they think is unconstitutional.
* Prop 304: would increase legislator's salaries to $35,000/year.
* Prop 303: would permit a manufacturer to give or sell investigational drugs, biological products, and medical devices to terminally ill patients even though the FDA has not cleared them for general use.